. 2022 Oct 5;2022:9385459. doi: 10.1155/2022/9385459

Table 4.

Comparison of the craniocervical flexion and 8 domain of SF 36 between the experimental and control group after 2 weeks of treatment.

Variable	Group (n = 88) Experimental = 44 Control = 44	After 2^nd week IQR	After 2^nd week mean ranks	Man Whitney U	Sig. (2-tailed)
Craniocervical flexion	Experimental	24 (24 to 26)	50.28	713.5	p = 0.029, d = 0.465
Craniocervical flexion	Control	23 (22 to 26)	38.72	713.5	p = 0.029, d = 0.465
Physical functioning–SF36	Experimental	57.5 (35 to 70)	46.6	875.50	p = 0.439, d = 0.165
Physical functioning–SF36	Control	52.5 (30 to 65)	42.4	875.50	p = 0.439, d = 0.165
Role limitation due to physical health–SF36	Experimental	25 (25 to 50)	53.3	581.0	p = 0.01, d = 0.733
Role limitation due to physical health–SF36	Control	0 (0 to 25)	35.7	581.0	p = 0.01, d = 0.733
Role limitation due to emotional problem–SF36	Experimental	33.3 (0 to 66.7)	46.14	896.00	p = 0.526, d = 0.128
Role limitation due to emotional problem–SF36	Control	16.65 (0 to 66.7)	42.86	896.00	p = 0.526, d = 0.128
Energy/fatigue–SF36	Experimental	55 (45 to 60)	50.6	699.50	p = 0.023, d = 0.493
Energy/fatigue–SF36	Control	45 (36.25 to 55)	38.4	699.50	p = 0.023, d = 0.493
Emotional wellbeing–SF36	Experimental	56 (52 to 64)	52.47	617.50	p = 0.003, d = 0.657
Emotional wellbeing–SF36	Control	52 (40 to 60)	36.53	617.50	p = 0.003, d = 0.657
Social functioning–SF36	Experimental	62.5 (50 to 75)	50.03	724.50	p = 0.037, d = 0.445
Social functioning–SF36	Control	50 (37.5 to 62.5)	38.97	724.50	p = 0.037, d = 0.445
Pain–SF36	Experimental	55 (45 to 68.87)	46.78	867.50	p = 0.382, d = 0.18
Pain–SF36	Control	45 (45 to 67.5)	42.22	867.50	p = 0.382, d = 0.18
General health perception–SF36	Experimental	52.5 (40 to 65)	52.99	594.50	p = 0.002, d = 0.706
General health perception–SF36	Control	40 (35 to 50)	36.01	594.50	p = 0.002, d = 0.706